At the core of Verida is Spectral Precise Image technology paired with a third-generation Nano-panel Precise dual-layer detector and an AI-based deep learning reconstruction engine
ENFLONSIA is a long-acting monoclonal antibody designed to shield infants through a typical five-month RSV season with a single, fixed dose
The company stated that it will work closely with the regulator to address the observations within the stipulated timeframe
The company allocated €56 million to research and development for next-generation line solutions
The company reported net revenue of SEK 13.5 million for the full year 2025
The programme is being implemented in collaboration with Grow Well Foundation and is expected to expand in a phased manner
This combination works to break down rough patches, improve moisture retention, and enhance overall skin texture
Revvity is positioning its technologies as a connected engine for discovery
Zero-observation outcomes strengthen global credibility and accelerate CDMO ambitions
Acquires 85% stake in the formulations company valued at Rs 200 crore enterprise value; founder Vivek Seth to retain 15%
Subscribe To Our Newsletter & Stay Updated
